Chemical Structure (Dc 1)
Dofetilide Capsule
Product Images NDC 42794-046
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dofetilide (NDC 42794-046). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sigmapharm Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Dc 2)
Figure 2 (Dc 3)
Figure 3 (Dc 4)
Figure 4 (Dc 5)
Flow Chart (Dc 6)
This text provides medical instructions for using the drug dofetilide to treat patients with certain heart conditions. The instructions include checking the patient's baseline QTc or QT levels, calculating their creatinine clearance, and adjusting the dosage of the medication based on these factors. The text also specifies when the drug is contraindicated and when it should be discontinued.*
Principal Display Panel (125 mcg (0.125 mg) Capsules Bottle Label)
Principal Display Panel (250 mcg (0.25 mg) Capsules Bottle Label)
This is a medication called Dofetilide available in capsules with a strength of 250 mcg (0.25 mg). It is recommended that the pharmacist provides each patient with a medication guide. The standard dosage is listed in the package insert. It should be stored at 20° to 25°C (68° to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F) and kept away from moisture and humidity. The medicine must be dispensed in a tight container with a child-resistant closure. Sigmapharm Laboratories in Bensalem, PA is the manufacturer of this medication.*
Principal Display Panel (500 mcg (0.5 mg) Capsules Bottle Label)
This is a prescription medication with the name Dofetilide, which is a capsule. It is available in a pack of 60 capsules. Each capsule contains 500 mcg (0.5 mg) dofetilide, USP. The package insert should be reviewed for complete prescribing information. The medication should be stored at 20° to 25°C (68° to 77°F), and should be protected from moisture and humidity. This product should be dispensed in a tight container with a child-resistant closure. The text also includes a note to the pharmacist to dispense an accompanying medication guide to each patient. No additional information is available.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
